we…are…reducing the size of the company by about 40%…this will impact around 4,000 people…we're working to give clarity to everyone as quickly as we can…thank you.jack.
2026年JPM（摩根大通医疗健康大会）上，已有多家跨国药企、美元基金提及，一些中国药企开始相对激进地对交易作价有不切实际的“高价预期”。之前几年，中国新药资产估值整体处于“性价比可观”的合理区间，若故意一味追求越来越高的“天价”，或有损中国Biotech在全球的口碑，不利于在中美医药行业间形成良性的生态循环。
。关于这个话题，PDF资料提供了深入分析
Essential digital access to quality FT journalism on any device. Pay a year upfront and save 20%.。电影是该领域的重要参考
France vs. Ireland — 8:10 p.m. GMT on Feb. 5 (ITV)
Lex: FT's flagship investment column